Translational lung cancer research
KRAS under attack: recent advances in targeted therapies involving G12C inhibitors and XPO1 inhibition.
Markus Falk, Stefanie Schatz, Markus Tiemann, Joachim H Ficker, Wolfgang M Brueckl
Published: 202510.21037/tlcr-2025-665
No abstract available for this study.